MedWorld Advisors Supports Acquisition of Behavior Science Technology in Strategic Sale to CentralReach
Boston, MA – MedWorld Advisors, a leading healthcare focused International M&A advisory firm, is pleased to announce the successful acquisition of its client, Behavior Science Technology (BST), to CentralReach, the leading provider of Autism and IDD Care software for Applied Behavior Analysis (ABA) providers. This strategic acquisition enhances CentralReach's position in the behavioral health technology space and expands its offerings to provide measurement-based care that will help enhance the quality and consistency of care provided to individuals with autism.
Behavior Science Technology, a leader in advancing quality standards in ABA care, has focused on addressing the vital need for accurate treatment fidelity data, a key challenge faced by ABA providers. The company’s innovative platform, BSTperform, enables organizations to leverage data for more informed decision-making, improving care quality, strengthening workforce performance and retention, and ultimately enhancing patient outcomes and access to services.
"We are excited to join forces with CentralReach, a company that shares our commitment to advancing behavioral health technology," said Troy Glick, COO of Behavior Science Technology. "This partnership will allow us to scale our solutions, reach more professionals, and continue innovating to meet the evolving needs of the industry. MedWorld Advisors played a critical role in guiding us through this process, and we are grateful for their expertise and support."
CentralReach’s acquisition of BST aligns with its strategy to expand its portfolio of industry-leading technology solutions for autism and IDD care providers. By integrating BST’s technology, CentralReach aims to enhance its comprehensive platform, delivering greater value to clients and driving better outcomes for individuals with autism and other developmental disabilities.
"Behavior Science Technology’s innovative approach and deep understanding of the behavioral health sector made it a standout partner for CentralReach," said Daniel Sheppard, Managing Director of Middle Markets at MedWorld Advisors. "We are proud to have facilitated this transaction, which underscores the importance of technology in advancing care delivery. This acquisition is a testament to BST’s achievements and CentralReach’s commitment to expanding its impact in the field."
MedWorld Advisors served as the exclusive sell-side advisor to Behavior Science Technology, providing strategic guidance throughout the transaction process. The collaboration reflects MedWorld Advisors’ continued dedication to helping healthcare companies achieve successful outcomes in the M&A market.
For more information about Behavior Science Technology, please visit www.behaviorsciencetech.com. To learn more about CentralReach, please visit www.centralreach.com.
About Behavior Science Technology
Behavior Science Technology is a leader in behavioral health technology, offering advanced solutions that empower clinicians to deliver high-quality care, streamline workflows, and improve client outcomes.
About CentralReach
CentralReach is a leading provider of electronic medical record (EMR), practice management, and data collection software for autism and IDD care providers. CentralReach’s solutions are used by thousands of organizations globally to enhance care quality and operational efficiency.
About MedWorld Advisors
MedWorld Advisors is a premier M&A advisory firm specializing in healthcare and medicaltechnologies. With a focus on the lower middle market, MedWorld Advisors partners with companies to navigate complex transactions, providing tailored strategies that drive value and achieve successful outcomes.
Contact Information:
MedWorld Advisors
Daniel Sheppard - Managing Director, Middle Markets
daniel@medworldadvisors.com
805-441-0962
To view the CentralReach press release, click here.
